Active Not RecruitingACTRN12605000634673
Official study titleIn a patient preference trial with people who attempt suicide does problem solving therapy compared to usual treatment reduce repetition, depression and suicidality one year after the index attempt.
This study is no longer accepting new participants.
In New ZealandSuicidalityInterventional studyAges 16+
- Countries
- New Zealand
- Sponsor
- University of Auckland
Enrolling By InvitationNCT05852860
Official study titleA Patient-Oriented Research Mentoring Program in Tobacco Dependence and Implementation Science Research: Improving Tobacco Treatment Rates for People Living With HIV Who Smoke
This study is by invitation only.
In PhiladelphiaAddictionInterventional study
- Countries
- United States
- Sponsor
- Abramson Cancer Center at Penn Medicine
Active Not RecruitingNCT04902391
About this title
A Patient-Partnered, Pan-Canadian, Comparative Effectiveness Evaluation of an Acute Pediatric Mental Health and Addiction Care Bundle
Read the official source — NCT04902391Official study titleA Multi-Disciplinary, Patient-Partnered, Pan-Canadian, Comparative Effectiveness Evaluation of an Innovative Acute Pediatric Mental Health and Addiction Care Bundle
This study is no longer accepting new participants.
Multiple locations, including WinnipegAddictionInterventional studyAges 8–17
- Countries
- Canada
- Sponsor
- University of Calgary
CompletedNCT05789212
Official study titleA Personalized (N-of-1) Trial for Testing the Effect of a Mind-Body Intervention (MBI) on Sleep Duration and Quality in Middle-Aged Women Working in Healthcare
This study has finished and is no longer accepting participants.
In New YorkAnxietyBehavioural studyAges 40–60
- Countries
- United States
- Sponsor
- Northwell Health
CompletedNCT01923025
Official study titleA Single Centre, Open Label Study to Characterize the PK-PDE10A Enzyme Occupancy Relationship of RO5545965 After a Single Dose in Healthy Male Volunteers Using [11C]IMA107 Positron Emission Tomography
This study has finished and is no longer accepting participants.
In LondonSchizophreniaMedication studyAges 25–50
- Countries
- United Kingdom
- Sponsor
- Hoffmann-La Roche